-
-
-
2024 Global CAR-T Sales Performance
CAR-T
Discover the sales performance of CAR-T therapies in 2024, including Kymriah, Yescarta, Breyanzi, and more. Explore trends, growth, and challenges in the CAR-T cell therapy market across the US and beyond.
-
-
Novartis 2024 Q4 Financial Report
Financial statements
Novartis' 2024 financial report highlights strong growth with key products like Entresto, Cosentyx, and Pluvicto. The company saw a 12% revenue increase, with China market sales up 21%. Strong prospects include new treatments and strategic acquisitions.
-
Top 10 Immunology Drugs to Watch in 2024
AbbVie
Explore the top 10 best-selling immunology drugs of 2023, including Humira, Dupixent, Stelara, and more. Discover how these innovative therapies are shaping the market, driving clinical breakthroughs, and overcoming competitive challenges.
-
November Biopharmaceutical Company Layoff Summary
Layoff
November 2024 saw significant layoffs in the biopharma industry, with 20 companies announcing cuts due to economic pressures, failed projects, and restructuring. Key layoffs include major firms like 23andMe, Novartis, and Bristol Myers Squibb.
-
-
-
珠海市|
新兴县|
手游|
徐水县|
吉木萨尔县|
绥宁县|
合肥市|
汾阳市|
和田县|
苍南县|
通州区|
徐闻县|
徐水县|
奉节县|
承德县|
淅川县|
东城区|
金坛市|
革吉县|
襄汾县|
安岳县|
阿尔山市|
西华县|
环江|
洪泽县|
石渠县|
吉木萨尔县|
潢川县|
凯里市|
旬阳县|
黑龙江省|
随州市|
哈密市|
灌南县|
溧阳市|
始兴县|
丽江市|
布尔津县|
寿宁县|
吉安县|
紫金县|